Paclitaxel and gemcitabine combinational drug-loaded mucoadhesive delivery system in the treatment of colon cancers

Drug Research

Volumn 65, Issue 4, 2015, Pages 199-204

  Guo, X Y ^a   Wang, P ^a   Du, Q G ^a   Han, S ^b   Zhu, S M ^a   Lv, Y F ^a   Liu, G S ^a   Hao, Z M ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

chemotherapeutic efficacy; colon cancer; combinational drug; nanoparticles; pH sensitivity

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE; CHITOSAN; DEOXYCYTIDINE; DRUG CARRIER; GEMCITABINE; NANOPARTICLE; PACLITAXEL; SUCCINIC ANHYDRIDE;

ANALOGS AND DERIVATIVES; ANIMAL; CELL CYCLE; CELL SURVIVAL; CHEMISTRY; COLONIC NEOPLASMS; DRUG COMBINATION; DRUG EFFECTS; DRUG RELEASE; DRUG SCREENING; HUMAN; MOUSE; SURVIVAL RATE; TUMOR CELL LINE;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL CYCLE; CELL LINE, TUMOR; CELL SURVIVAL; CHITOSAN; COLONIC NEOPLASMS; DEOXYCYTIDINE; DRUG CARRIERS; DRUG LIBERATION; DRUG THERAPY, COMBINATION; HUMANS; MICE; NANOPARTICLES; PACLITAXEL; SUCCINIC ANHYDRIDES; SURVIVAL RATE; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84929516779     PISSN: 21949379     EISSN: 21949387     Source Type: Journal    
DOI: 10.1055/s-0034-1375665     Document Type: Article

References (15)

1. WHO Media Centre WHO Fact Sheet No. 297, Cancer: 2012; http://www.who.int/mediacentre/factsheets/fs297/en/
2. Chuah L. H., Roberts C. J., Billa N. et al. Cellular uptake and anticancer effects of mucoadhesive curcumin-containing chitosan nanoparticles. Colloids and Surfaces B: Biointerfaces: 2014; 116 228 236
3. Ma Y., Coombes AGA. Designing colon-specific delivery systems for anticancer drug-loaded nanoparticles: An evaluation of alginate carriers. J Biomed Mat Res Part A: 2013
4. Rekha M. R., Sharma C. P. pH sensitive succinyl chitosan microparticles: a preliminary investigation towards oral insulin delivery. Trends Biomater Artif Organs: 2008; 21 107 115
5. Yan C., Chen D., Gu J. et al. Preparation of N-succinyl-chitosan and its physical-chemical properties as a novel excipient. Yakugaku Zasshi: 2006; 126 789 793
6. Jain R. K., Stylianopoulos T. Delivering nanomedicines to solid tumors. Nat Rev Drug Discov: 2010; 7 653 664
7. Acharya S., Sahoo S. K. Sustained targeting of Bcr-Abl+leukemia cells by synergistic action of dual drug loaded nanoparticles and its implication for leukemia therapy. Biomaterials: 2011; 32 5643 5662
8. Hu JC M., Zhang L. Nanoparticle-based combination therapy toward overcoming drug resistance in cancer. Biochem Pharmacol: 2012; 83 1104 1111
9. Lammers T., Subr V., Ulbrich K. et al. Simultaneous delivery of doxorubicin and gemcitabine to tumors in vivo using prototypic polymeric drug carriers. Biomaterials: 2009; 30 3466 3475
10. Mura C., Nácherb A., Merinob V. et al. Design, characterization and in vitro evaluation of 5-aminosalicylic acid loaded N-succinyl-chitosan microparticles for colon specific delivery. Colloids and Surfaces B: Biointerfaces: 2012; 94 199 205
11. Zhang L., Radovic-Moreno A. F., Alexis F. et al. Co-Delivery of Hydrophobic and Hydrophilic Drugs from Nanoparticle-Aptamer Bioconjugates. ChemMedChem: 2007; 2 1268 1271
12. Carrion C., de Madariaga M. A., Domingo J. C. In vitro cytotoxic study of immunoliposomal doxorubicin targeted to human CD34(+) leukemic cells. Life Sci: 2004; 75 313 328
13. Ji X., Gaoa Y., Chen L. et al. Nanohybrid systems of non-ionic surfactant inserting liposomes loading paclitaxel for reversal of multidrug resistance. Int J Pharm: 2012; 422 390 397
14. Gabizon A. A. Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes. Cancer Res: 1992; 52 891 896
15. Saxena V., Hussain M. D. Formulation and in vitro evaluation of 17-allyamino-17-demethoxygeldanamycin (17-AAG) loaded Polymeric mixed micelles for glioblastomamultiforme. Colloids and Surfaces B:Biointerfaces: 2013; 112 350 355